The Risks of Foreign Investment in U.S. Life Sciences Companies 06.07.2025 16:10 PM In recent years, Chinese investment in U.S. and global biotech and medtech has increased significantly. These partnerships can serve as strategic footholds, raising complex questions around security, sovereignty, and long-term strategy.
Trump Administration Declares COVID-19 Likely Originated from Wuhan Lab Leak, Citing Scientific Evidence
SPACEVoyager 2’s Historic Uranus Flyby May Have Captured Rare Event, Changing Scientists’ View of the Planet
MEDICINE & HEALTHColorectal Cancer Deaths Increasing Among Millennials and Gen X: Learn the Warning Signs
